Nebenwirkungen · Zalasta
Zalasta 2.5 mg tablets Zalasta 5 mg tablets Zalasta 7.5 mg tablets Zalasta 10 mg tablets Zalasta 15 mg tablets Zalasta 20 mg tablets · Abschnitt 4.8 · PDF-Seite 9
HOS-118129 · Präparat HOS-094761
Neutropenia10 Immune system disorders Hypersensitivity11 Metabolism and nutrition disorders Weight gain1 Elevated cholesterol Development or Hypothermia12 levels2,3 exacerbation of Elevated glucose diabetes occasionally levels4 associated with Elevated triglyceride ketoacidosis or coma, levels2,5 including some fatal Glucosuria cases (see section Increased appetite 4.4)11 Nervous system disorders Somnolence Dizziness Seizures where in most Neuroleptic Akathisia6 cases a history of malignant Parkinsonism6 seizures or risk factors syndrome (see Dyskinesia6 for seizures were section 4.4)12 reported11 Discontinuation Dystonia (including symptoms7, 12 oculogyration)11 Tardive dyskinesia11 Amnesia9 Dysarthria Stuttering11 Restless legs syndrome11 Cardiac disorders Bradycardia Ventricular QTc prolongation (see tachycardia/fibrillat section 4.4) ion, sudden death (see section 4.4)11 Vascular disorders Orthostatic Thromboembolism hypotension10 (including pulmonary embolism and deep vein thrombosis) (see section 4.4) Respiratory, thoracic and mediastinal disorders Epistaxis9 Gastrointestinal disorders Mild, transient Abdominal distension9 Pancreatitis11 anticholinergic effects Salivary including constipation hypersecretion11 and dry mouth
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-03-08T12:05:00Z · SHA-256 3a142a418d0e0a235e959dcbf43b8874bc768eb3299e63f7c0947414404ebe0b · Passage dccc3ff6fb489eb58bea90f213f2ef730235f83365b9bfab560ff1e16e7cad6e · Zeichen 1655–4663 im Abschnitt